Nearly half of BioSpace poll respondents recently took a biopharma job they were overqualified for, a finding that didn’t ...

We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. So, here we are ...

The Brevard-based doctor and former congressman said: "The concern of many people is that big Pharma was behind this, which ...

Xeris Biopharma (XERS) shares ended the last trading session 5.6% higher at $5.51. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...

"As the biopharmaceutical industry evolves, aligning our client programs with our corporate strategy is essential to ensuring long-term success,” said Benedikt von Braunmühl, CEO of Rentschler ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Powered by Real-World Expertise: Cliniphai has built deep operational experience across clinical studies and is working with trusted partners that have spent decades ensuring linguistic accuracy in ...

IAG Cargo’s Constant Climate cold chain solution that facilitates the transportation of pharmaceuticals, such as vaccines, ...